Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Houston › NPI 1790188027
Physician

Pediatrics of Greater Houston, PLLC

Pediatrics of Greater Houston, PLLC was paid $3.12M by Medicaid between Oct 2019 and Dec 2023, across 54 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.

33Billing provider infoPEDIATRICS OF GREATER HOUSTON, PLLC
HOUSTON, TX 77054
33aNPI1790188027assigned 10/01/2014
33bProvider typePediatrics Physician
28Total paid$3.12M
24GClaims111,605
24DCodes billed54
24AFirst – last monthOct 2019 – Dec 2023
Compared with peers

Next to other Pediatrics Physician providers in Texas

Rank by total paid#152 of 1,136
Median peer was paid$329K
This provider vs. median9.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WADLINGTON, NICHOLAS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201956$431.21
20207,018$173K
202138,803$1.04M
202236,264$1.05M
202329,464$854K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 21% 17,821 16,114 $649K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 19% 8,526 7,383 $590K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 17% 6,614 6,147 $519K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 8.3% 3,595 3,046 $259K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 5.1% 1,794 1,674 $158K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4.7% 2,875 2,710 $147K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 4.0% 12,557 12,246 $126K
90472 Immunization administration, each additional vaccine (list separately) 3.8% 13,377 9,101 $119K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 3.3% 2,059 1,941 $104K
99238 Hospital discharge day management, 30 minutes or less 2.6% 1,349 1,306 $80K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2.5% 2,750 2,606 $77K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2.3% 943 882 $71K
42 more codes
99460 1.6% 638 $49K
90474 1.2% 4,134 $37K
96110 Developmental screening, with scoring and documentation, per standardized instrument 1.1% 3,935 $34K
99223 Prolong inpt eval add15 m <1% 207 $26K
99381 <1% 243 $15K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 549 $13K
99462 <1% 241 $9K
90670 <1% 4,640 $7K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 65 $4K
99203 Doctor's office visit, new patient (routine) <1% 79 $4K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 610 $4K
0071A <1% 94 $4K
90651 <1% 652 $2K
90680 <1% 4,150 $2K
99239 Hospital discharge day management, more than 30 minutes <1% 14 $1K
99383 <1% 14 $1K
17250 <1% 17 $959.58
0072A <1% 25 $941.56
90734 <1% 126 $922.20
90671 <1% 937 $873.96
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 44 $579.52
90710 <1% 1,045 $482.08
81002 <1% 162 $470.50
90744 <1% 1,048 $467.19
90633 <1% 2,612 $421.25
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 27 $357.79
90619 <1% 344 $333.40
90686 <1% 1,783 $323.83
90716 <1% 657 $305.82
90677 <1% 338 $268.76
90698 <1% 3,632 $92.71
90707 <1% 639 $84.10
81000 <1% 18 $53.25
90696 <1% 444 $52.46
90715 <1% 208 $31.50
90697 <1% 2,080 $0.70
96127 0% 667 $0.00
91307 0% 166 $0.00
90620 0% 14 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 0% 15 $0.00
90648 0% 16 $0.00
90700 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWADLINGTON, NICHOLAS (GROUP VICE PRESIDENT)
Same official

Other billing entities under WADLINGTON, NICHOLAS

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.